Keyphrases
Antithrombotic Therapy
100%
New-onset Atrial Fibrillation
100%
Vitamin K Antagonists
100%
Antiplatelet
100%
Treatment Patterns
100%
Atrial Fibrillation
66%
Baseline Characteristics
66%
Anticoagulants
66%
CHA2DS2-VASc
66%
Hypertension
33%
Diabetes
33%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
33%
Vascular Disease
33%
Anticoagulant Therapy
33%
Stroke Risk
33%
Newly Diagnosed
33%
Newly Diagnosed Patients
33%
Antiplatelet Monotherapy
33%
Non-valvular Atrial Fibrillation
33%
Current Smokers
33%
Guideline-directed Medical Therapy
33%
Working Diagnosis
33%
Stroke Risk Factors
33%
Am(III)
33%
Elderly Patients
33%
Renal Comorbidities
33%
Cardiac Failure
33%
Dementia
33%
Vascular Comorbidity
33%
Asian Ethnicity
33%
Medicine and Dentistry
Antithrombotic
100%
Atrial Fibrillation
100%
Antiplatelet
100%
Apoplexy
75%
Vitamin K Antagonist
75%
CHA2DS2-VASc Score
50%
Antithrombotic Therapy
50%
Diabetes
25%
Nonsteroid Antiinflammatory Agent
25%
Smoking
25%
Monotherapy
25%
Anticoagulant Therapy
25%
Congestive Heart Failure
25%
Vascular Disease
25%
Elderly Patient
25%
Comorbidity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Atrial Fibrillation
100%
Antiplatelet
100%
Antivitamin K
75%
Cerebrovascular Accident
75%
Antithrombotic Therapy
50%
Monotherapy
25%
Non-Steroidal Anti-Inflammatory Drug
25%
Congestive Heart Failure
25%
Vascular Disease
25%
Comorbidity
25%
Neuroscience
Antithrombotic
100%
Atrial Fibrillation
100%
Anticoagulant
50%
Vitamin K Antagonist
50%
Cerebrovascular Accident
50%
Non-Steroidal Anti-Inflammatory Drug
16%
Vascular Disease
16%
Comorbidity
16%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
100%
Vitamin K
75%
Smoking
25%
Comorbidity
25%